With an ion the bottom line, Biohaven signs SK epilepsy deal BioWorld 20:56 Thu, 27 Aug Article paywall
SK inks $795m Biohaven epilepsy deal, entering potassium channel opener race Pharmaceutical Technology 16:54 Thu, 27 Aug
Biohaven And SK Biopharmaceuticals Enter Strategic Global Licensing Agreement; Stock Up RTT News 09:48 Wed, 26 Aug
Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy PR Newswire (Press Release) 07:39 Wed, 26 Aug
SK Biopharmaceuticals signs $795 million licensing deal with Biohaven for epilepsy drug Korea JoongAng Daily 04:24 Wed, 26 Aug
Is Biohaven (BHVN) Undervalued Following Its Latest Earnings Loss Improvement? Simply Wall St 20:38 Sun, 23 Aug
Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results PR Newswire (Press Release) 21:05 Mon, 10 Aug
Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors PR Newswire (Press Release) 12:00 Thu, 06 Aug
